PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
20.82%
Revenue growth above 1.5x MCHP's 10.82%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
177.57%
Gross profit growth above 1.5x MCHP's 15.09%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
251.26%
EBIT growth above 1.5x MCHP's 140.04%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
251.26%
Operating income growth above 1.5x MCHP's 132.00%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-44.77%
Negative net income growth while MCHP stands at 87.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-60.00%
Negative EPS growth while MCHP is at 70.34%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-60.00%
Negative diluted EPS growth while MCHP is at 70.34%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
19.85%
Share count expansion well above MCHP's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
19.85%
Diluted share count expanding well above MCHP's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
58.73%
Dividend growth above 1.5x MCHP's 10.17%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.52%
10Y revenue/share CAGR at 75-90% of MCHP's 51.09%. Bill Ackman would press for new markets or product lines to narrow the gap.
39.52%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
28.30%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
179.25%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
179.25%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
24.43%
Positive short-term CAGR while MCHP is negative. John Neff would see a clear advantage in near-term profit trajectory.
57.92%
Below 50% of MCHP's 145.07%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
57.92%
5Y equity/share CAGR above 1.5x MCHP's 14.52%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
32.66%
3Y equity/share CAGR above 1.5x MCHP's 17.81%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-14.28%
Cut dividends over 10 years while MCHP stands at 180.63%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-14.28%
Negative 5Y dividend/share CAGR while MCHP stands at 175.02%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-14.28%
Negative near-term dividend growth while MCHP invests at 81.65%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
4.15%
AR growth is negative/stable vs. MCHP's 10.99%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-9.16%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.64%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-15.87%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
2.31%
We have some new debt while MCHP reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
0.37%
SG&A declining or stable vs. MCHP's 4.80%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.